Ranitidine kinetics in normal subjects. 1982

N P Chau, and P Y Zech, and N Pozet, and A Hadj-Aissa

A 1-mg/kg IV bolus injection and a 150-mg (one tablet) oral dose of ranitidine were given to seven normal subjects. At least 1 wk separated the two doses. Ranitidine disappeared from plasma with a half-life of about 2.5 hr. Half of the oral dose was effectively absorbed and half of the absorbed amount was found unchanged in urine. Total body clearance was 10.1 ml/min/kg. Urinary clearance was the same after oral and intravenous doses (6.4 and 6.9 ml/min/kg, P greater than 0.10). Intravenous ranitidine kinetics included three phases, with a central distribution volume of 0.2 l/kg and a total distribution volume of 1.2 l/kg. Absorption kinetics were apparently order zero: of the 150-mg dose, 75 mg was absorbed during 5 hr at a constant rate of 15 mg/hr.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D005260 Female Females
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

N P Chau, and P Y Zech, and N Pozet, and A Hadj-Aissa
April 1983, Clinical pharmacology and therapeutics,
N P Chau, and P Y Zech, and N Pozet, and A Hadj-Aissa
September 1981, Clinical pharmacology and therapeutics,
N P Chau, and P Y Zech, and N Pozet, and A Hadj-Aissa
February 1983, Gut,
N P Chau, and P Y Zech, and N Pozet, and A Hadj-Aissa
February 1986, Digestive diseases and sciences,
N P Chau, and P Y Zech, and N Pozet, and A Hadj-Aissa
September 1973, North Carolina medical journal,
N P Chau, and P Y Zech, and N Pozet, and A Hadj-Aissa
July 1971, Annals of the New York Academy of Sciences,
N P Chau, and P Y Zech, and N Pozet, and A Hadj-Aissa
July 1983, The British journal of dermatology,
N P Chau, and P Y Zech, and N Pozet, and A Hadj-Aissa
September 1984, Clinical pharmacology and therapeutics,
N P Chau, and P Y Zech, and N Pozet, and A Hadj-Aissa
April 1990, Alimentary pharmacology & therapeutics,
N P Chau, and P Y Zech, and N Pozet, and A Hadj-Aissa
October 1998, Acta ophthalmologica Scandinavica,
Copied contents to your clipboard!